Oral antiparasitic drug ivermectin may significantly reduce the risk of contracting Covid-19:study

Credit: indiamart.com

The research, published in the May-June issue of the American Journal of Therapeutics, is the most comprehensive review of the available data on ivermectin taken from clinical, in vitro, animal, and real-world studies, its authors said. Regular use of the oral antiparasitic drug ivermectin may significantly reduce the risk of contracting Covid-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.

WHO warns against use of Ivermectin
'Safety and efficacy are important when using any drug for a new indication. @WHO recommends against the use of ivermectin for Covid-19 except within clinical trials,' Soumya Swaminathan, the global health body's chief scientist, said in a tweet

A similar warning has also been issued by 'ivermectin' manufacturer MSD, or Merck & Co., Inc, whose statement Dr Swaminathan attached to her tweet. Merck said its scientists continue to "carefully examine findings of all available and emerging studies of 'ivermectin' for treatment of COVID-19".

Goa Recommends Ivermectin to All Above 18 After

oa government on Monday cleared a new Covid-19 treatment protocol which recommends all residents above the age of 18 to take five tablets of the ivermectin drug, in order to prevent the steep and sometimes fatal viral fever, which accompanies a Covid-19 infection.

Speaking to reporters here, Health Minister Vishwajit Rane said that the ivermectin drug would be made available at all health centres in the state and should be taken by all residents, irrespective of whether they have Covid-19 symptoms or otherwise. “We are giving this as a prophylaxis treatment, as a preventive. Ivermectin tablets will be given to all patients above 18 years at government health centres. The population needs to take the population. This will be made available," he said.

Current Issue

NEWSLETTER